TWO DOSAGES DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH HIGH RISK OF STROKE AND EMBOLISM UNDERGOING ELECTRICAL CARDIOVERSION WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION

Autor:	Aldis Strelnieks, Kaspars Kupics, Andrejs Erglis, Marina Kovalova, Iveta Sime, Maija Vikmane, Milana Zabunova, Oskars Kalejs, Olga Litunenko, Baiba Lurina, Sandis Sakne, Aivars Lejnieks
Rok vydání:	2015
Předmět:	medicine.medical_specialty Dose business.industry Warfarin Atrial fibrillation macromolecular substances medicine.disease Dabigatran Long acting Embolism Internal medicine medicine Cardiology In patient business Cardiology and Cardiovascular Medicine Stroke medicine.drug
Zdroj:	Journal of the American College of Cardiology. 65(10)
ISSN:	0735-1097
DOI:	10.1016/s0735-1097(15)60353-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55af7a58b9487090cd01db4a97b3d73 Zobrazit plný text záznamu